These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24984269)

  • 1. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production.
    Zeng W; Chang H; Ma M; Li Y
    Exp Mol Pathol; 2014 Aug; 97(1):184-90. PubMed ID: 24984269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment of CCR6-expressing Th17 cells by CCL20 secreted from plasmin-stimulated macrophages.
    Li Q; Laumonnier Y; Syrovets T; Simmet T
    Acta Biochim Biophys Sin (Shanghai); 2013 Jul; 45(7):593-600. PubMed ID: 23681234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 induces CC chemokine receptor 6 expression and cell migration in colorectal cancer cells.
    Chin CC; Chen CN; Kuo HC; Shi CS; Hsieh MC; Kuo YH; Tung SY; Lee KF; Huang WS
    J Cell Physiol; 2015 Jul; 230(7):1430-7. PubMed ID: 25201147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway.
    Jin P; Shin SH; Chun YS; Shin HW; Shin YJ; Lee Y; Kim D; Nam DH; Park JW
    Oncogene; 2018 Jun; 37(23):3070-3087. PubMed ID: 29535421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation.
    Punj V; Matta H; Schamus S; Yang T; Chang Y; Chaudhary PM
    Blood; 2009 May; 113(22):5660-8. PubMed ID: 19324905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma.
    Du D; Liu Y; Qian H; Zhang B; Tang X; Zhang T; Liu W
    Int J Mol Sci; 2014 Apr; 15(4):6441-52. PubMed ID: 24743888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.
    Coperchini F; Pignatti P; Carbone A; Bongianino R; Di Buduo CA; Leporati P; Croce L; Magri F; Balduini A; Chiovato L; Rotondi M
    Tumour Biol; 2016 Apr; 37(4):5569-75. PubMed ID: 26577851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA‑u50535 promotes the progression of lung cancer by activating CCL20/ERK signaling.
    Wei W; Zhao X; Zhu J; Zhang L; Chen Y; Zhang B; Li Y; Wang M; Zhang Z; Wang C
    Oncol Rep; 2019 Nov; 42(5):1946-1956. PubMed ID: 31545478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.
    Shih YT; Wang MC; Peng HH; Chen TF; Chen L; Chang JY; Chiu JJ
    Cell Signal; 2012 Mar; 24(3):779-93. PubMed ID: 22120522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR6/CCL20 chemokine expression profile in distinct colorectal malignancies.
    Frick VO; Rubie C; Kölsch K; Wagner M; Ghadjar P; Graeber S; Glanemann M
    Scand J Immunol; 2013 Sep; 78(3):298-305. PubMed ID: 23790181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
    Frick VO; Rubie C; Keilholz U; Ghadjar P
    World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients.
    Zhang CY; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
    Biomed Pharmacother; 2015 Feb; 69():242-8. PubMed ID: 25661365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway.
    Hou X; Zhang Y; Qiao H
    Tumour Biol; 2016 Jan; 37(1):641-51. PubMed ID: 26242263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression.
    Lee EJ; Lee SJ; Kim S; Cho SC; Choi YH; Kim WJ; Moon SK
    Cell Signal; 2013 Oct; 25(10):2025-38. PubMed ID: 23770289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway.
    Lu E; Su J; Zhou Y; Zhang C; Wang Y
    Biomed Pharmacother; 2017 Jan; 85():486-492. PubMed ID: 27916417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.
    Burke SJ; Karlstad MD; Regal KM; Sparer TE; Lu D; Elks CM; Grant RW; Stephens JM; Burk DH; Collier JJ
    Biochim Biophys Acta; 2015 Jun; 1849(6):637-52. PubMed ID: 25882704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
    Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
    Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.